e-ISSN: Pending
Negative / Null Result ReportOpen accessNeurology. Diseases of the nervous system

高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly

杨江胜,朱祖福,高志强,陆强彬,周国庆,方琪 · 2018 · Zhongguo cuzhong zazhi

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

目的 探讨高龄轻型缺血性卒中3 h内行阿替普酶静脉溶栓治疗的疗效及安全性。 方法 将我院2015年10月-2017年10月连续收治入院的发病3 h内48例高龄急性轻型缺血性卒中患者 随机分为阿替普酶静脉溶栓组24例和未溶栓组24例。比较两组患者入院时的一般情况,基线美国 国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NHISS)评分,治疗24 h后颅内出 血转化率,治疗后90 d改良Rankin量表(modified Rankin Scale,mRS)评分及90 d病死率。 结果 阿替普酶静脉溶栓组和未溶栓组患者一般临床资料、基线NIHSS评分比较,差异无统计学意 义。阿替普酶静脉溶栓组和未溶栓组治疗24 h后颅内出血转化率分别为4.17%和0(P =1.000),两组 90 d病死率均为4.17%(P =1.000),阿替普酶静脉溶栓组及未溶栓组90 d mRS评分为0~2分的比率 分别为83.33%和54.17%(P =0.029)。 结论 早期阿替普酶静脉溶栓治疗高龄急性轻型缺血性卒中不增加急性期颅内出血转化的风险, 可以改善高龄轻型缺血性卒中患者预后,不增加病死率。 Abstract: Objective To investigate the efficacy and safety of alteplase i

Abstract by 杨江胜,朱祖福,高志强,陆强彬,周国庆,方琪 , Zhongguo cuzhong zazhi (2018) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.3969/j.issn.1673-5765.2018.04.005